Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Lung Cancer · Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Royal University Hospital, Saskatoon, Saskatchewan, Canada
Ronald Geyer, PhD (Sub-investigator)Humphrey Fonge, PhD (Sub-investigator)Kris Barreto, PhD (Sub-investigator)Wendy Bernhard, PhD (Sub-investigator)